Regeneron Pharmaceuticals, Inc. (REGN)
Market Closed
17 Jul, 20:00
$
676. 69
-2.25
-0.3314%
$
69.71B Market Cap
24.52 P/E Ratio
0.22% Div Yield
648,300 Volume
42.79 Eps
$ 678.94
Previous Close 
Want to track REGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regeneron Pharmaceuticals, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 John Newman Canaccord Genuity | 2.13 | $1,315.88 | $1,414.05 | $98.17 | 7.46% |
 Tyler Van Buren TD Cowen | 36.82 | $26,283.47 | $24,466.45 | -$1,817.02 | -6.91% |
| GR Gregory Renza Truist Securities | 13.71 | $8,917.65 | $9,109.54 | $191.89 | 2.15% |
| RW Robert Wasserman Benchmark | 31.13 | $21,048.78 | $20,682.11 | -$366.67 | -1.74% |
| RK Rajesh Kumar HSBC | 153.89 | $100,000 | $104,202.75 | $4,202.75 | 4.2% |
